Testing effectiveness (Phase 2)UnknownNCT03544021
What this trial is testing
CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Who this might be right for
Leukemia, Lymphocytic, Acute
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10